Screening and prevention of alcohol and drug use disorders in women

Dace S. Svikis, Kathryn Reid-Quiñones

Research output: Contribution to journalArticle

Abstract

Today a variety of treatments are available for women with SUDs. They range from psychosocial interventions such as motivational enhancement therapy, cognitive-behavioral therapy, and 12-step recovery to pharmacotherapies such as buprenorphine, methadone, and naltrexone. Although the general public remains skeptical of SUD treatment, national studies consistently find it to be both clinically and economically efficacious [102]. In Oregon, for example, researchers found that every dollar invested in drug treatment saved taxpayers $5.60 [103]. By the time a woman walks through the door of a drug treatment program, however, her disorder is likely to be firmly engrained. The medical practitioner's office provides an ideal setting for screening and early identification of high-risk alcohol and other drug use and abuse. A variety of reliable and valid self-report measures are available. Sadly, however, the majority of health providers still do not routinely screen patients for alcohol or drug problems. The consequences can be severe, particularly for women. Although efforts have focused on practitioner education and strategies to address practical barriers to implementation (eg, time, resources), much less attention has focused on the pessimistic views of practitioners about SUDs and treatment efficacy. New strategies are needed to enhance practitioner feelings of self-efficacy about their ability to identify and intervene early in the progression from alcohol use to abuse to dependence.

Original languageEnglish (US)
Pages (from-to)447-468
Number of pages22
JournalObstetrics and Gynecology Clinics of North America
Volume30
Issue number3
DOIs
StatePublished - Sep 2003
Externally publishedYes

Fingerprint

Substance-Related Disorders
Alcohols
Pharmaceutical Preparations
Therapeutics
Buprenorphine
Naltrexone
Aptitude
Methadone
Cognitive Therapy
Self Efficacy
Self Report
Emotions
Research Personnel
Education
Drug Therapy
Health

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Screening and prevention of alcohol and drug use disorders in women. / Svikis, Dace S.; Reid-Quiñones, Kathryn.

In: Obstetrics and Gynecology Clinics of North America, Vol. 30, No. 3, 09.2003, p. 447-468.

Research output: Contribution to journalArticle

Svikis, Dace S. ; Reid-Quiñones, Kathryn. / Screening and prevention of alcohol and drug use disorders in women. In: Obstetrics and Gynecology Clinics of North America. 2003 ; Vol. 30, No. 3. pp. 447-468.
@article{d17cab64597540a984530c2117707179,
title = "Screening and prevention of alcohol and drug use disorders in women",
abstract = "Today a variety of treatments are available for women with SUDs. They range from psychosocial interventions such as motivational enhancement therapy, cognitive-behavioral therapy, and 12-step recovery to pharmacotherapies such as buprenorphine, methadone, and naltrexone. Although the general public remains skeptical of SUD treatment, national studies consistently find it to be both clinically and economically efficacious [102]. In Oregon, for example, researchers found that every dollar invested in drug treatment saved taxpayers $5.60 [103]. By the time a woman walks through the door of a drug treatment program, however, her disorder is likely to be firmly engrained. The medical practitioner's office provides an ideal setting for screening and early identification of high-risk alcohol and other drug use and abuse. A variety of reliable and valid self-report measures are available. Sadly, however, the majority of health providers still do not routinely screen patients for alcohol or drug problems. The consequences can be severe, particularly for women. Although efforts have focused on practitioner education and strategies to address practical barriers to implementation (eg, time, resources), much less attention has focused on the pessimistic views of practitioners about SUDs and treatment efficacy. New strategies are needed to enhance practitioner feelings of self-efficacy about their ability to identify and intervene early in the progression from alcohol use to abuse to dependence.",
author = "Svikis, {Dace S.} and Kathryn Reid-Qui{\~n}ones",
year = "2003",
month = "9",
doi = "10.1016/S0889-8545(03)00082-2",
language = "English (US)",
volume = "30",
pages = "447--468",
journal = "Obstetrics and Gynecology Clinics of North America",
issn = "0889-8545",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Screening and prevention of alcohol and drug use disorders in women

AU - Svikis, Dace S.

AU - Reid-Quiñones, Kathryn

PY - 2003/9

Y1 - 2003/9

N2 - Today a variety of treatments are available for women with SUDs. They range from psychosocial interventions such as motivational enhancement therapy, cognitive-behavioral therapy, and 12-step recovery to pharmacotherapies such as buprenorphine, methadone, and naltrexone. Although the general public remains skeptical of SUD treatment, national studies consistently find it to be both clinically and economically efficacious [102]. In Oregon, for example, researchers found that every dollar invested in drug treatment saved taxpayers $5.60 [103]. By the time a woman walks through the door of a drug treatment program, however, her disorder is likely to be firmly engrained. The medical practitioner's office provides an ideal setting for screening and early identification of high-risk alcohol and other drug use and abuse. A variety of reliable and valid self-report measures are available. Sadly, however, the majority of health providers still do not routinely screen patients for alcohol or drug problems. The consequences can be severe, particularly for women. Although efforts have focused on practitioner education and strategies to address practical barriers to implementation (eg, time, resources), much less attention has focused on the pessimistic views of practitioners about SUDs and treatment efficacy. New strategies are needed to enhance practitioner feelings of self-efficacy about their ability to identify and intervene early in the progression from alcohol use to abuse to dependence.

AB - Today a variety of treatments are available for women with SUDs. They range from psychosocial interventions such as motivational enhancement therapy, cognitive-behavioral therapy, and 12-step recovery to pharmacotherapies such as buprenorphine, methadone, and naltrexone. Although the general public remains skeptical of SUD treatment, national studies consistently find it to be both clinically and economically efficacious [102]. In Oregon, for example, researchers found that every dollar invested in drug treatment saved taxpayers $5.60 [103]. By the time a woman walks through the door of a drug treatment program, however, her disorder is likely to be firmly engrained. The medical practitioner's office provides an ideal setting for screening and early identification of high-risk alcohol and other drug use and abuse. A variety of reliable and valid self-report measures are available. Sadly, however, the majority of health providers still do not routinely screen patients for alcohol or drug problems. The consequences can be severe, particularly for women. Although efforts have focused on practitioner education and strategies to address practical barriers to implementation (eg, time, resources), much less attention has focused on the pessimistic views of practitioners about SUDs and treatment efficacy. New strategies are needed to enhance practitioner feelings of self-efficacy about their ability to identify and intervene early in the progression from alcohol use to abuse to dependence.

UR - http://www.scopus.com/inward/record.url?scp=0242404550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242404550&partnerID=8YFLogxK

U2 - 10.1016/S0889-8545(03)00082-2

DO - 10.1016/S0889-8545(03)00082-2

M3 - Article

C2 - 14664321

AN - SCOPUS:0242404550

VL - 30

SP - 447

EP - 468

JO - Obstetrics and Gynecology Clinics of North America

JF - Obstetrics and Gynecology Clinics of North America

SN - 0889-8545

IS - 3

ER -